Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients

Table 1 Clinical and biochemical characteristics from patients with celiac disease and control subjects

	Patients with celiac disease (n = 20)	Control subjects (n = 20)	P
Age (yr)	50 (25-58)	47 (28-60)	ns
Men/woman	5/15	5/15	ns
BMI (kg/m2)	22.8 (20.4-26.2)	23.0 (21.0-24.7)	ns
Glucose (mg/dL)	87 ± 11	86 ± 12	ns
Insulin (mU/L)	7.2 (5.0-11.3)	4.6 (2.6-6.7)	< 0.05
HOMA-IR	1.45 (1.04-2.24)	1.00 (0.51-1.45)	< 0.05
QUICKI	0.33 (0.28-0.40)	0.42 (0.34-0.65)	< 0.05
Urea (mg/dL)	27 (21-34)	35 (34-39)	< 0.01
Creatinine (mg/dL)	0.74 (0.63-0.88)	0.80 (0.75-1.10)	< 0.05
Uric acid (mg/dL)	5.0 ± 1.2	4.3 ± 1.6	ns
Bilirubin (mg/dL)	0.7 (0.5-0.8)	0.6 (0.6-0.8)	ns
ASAT (U/L)	26 (20-35)	14 (12-20)	< 0.01
ALAT (U/L)	22 (17-39)	18 (16-22)	ns
ALP (U/L)	80 (59-102)	124 (67-219)	ns

BMI: Body mass index; HOMA-IR: Homeostasis Model Assessment insulin resistance; QUICKI: Quantitative insulin sensitivity check index; ASAT: Aspartate-amine transferase; ALAT: Alanine-amine transferase; ALP: Alkaline phosphatase; ns: Non significant. Data are shown as mean ± SD or median (interquartile range) according to data distribution.